XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Stockholders' Equity - USD ($)
Preferred Stock [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Series D Preferred Stock [Member]
Preferred Stock [Member]
Series E Preferred Stock [Member]
Preferred Stock [Member]
Series F Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 70,151,000 $ (67,000) $ (66,096,000) $ 3,988,000
Balance, shares at Dec. 31, 2023 2,046,307        
Stock-based compensation
Currency translation adjustment (3,000) (3,000)
Exercise of pre-funded warrants
Exercise of pre-funded warrants, shares         738,000        
Exercise of options $ 107,000 $ 107,000
Rounding-up of fractional shares due to reverse stock split
Rounding-up of fractional shares due to reverse stock split, shares         46       47
Other comprehensive loss
Net loss (588,000) (588,000)
Balance at Mar. 31, 2024 70,258,000 (70,000) (66,684,000) 3,504,000
Balance, shares at Mar. 31, 2024 2,784,353        
Balance at Dec. 31, 2024 70,507,000 (80,000) (69,801,000) 627,000
Balance, shares at Dec. 31, 2024 378,941        
Currency translation adjustment   (1,000) (1,000)
Exercise of pre-funded warrants
Exercise of pre-funded warrants, shares         214,227        
Rounding-up of fractional shares due to reverse stock split
Rounding-up of fractional shares due to reverse stock split, shares         66,177       66,177
Net loss $ (2,495,000) $ (2,495,000)
Envizion Merger 36,921 36,921
Envizion Merger, shares         33,182        
Warrant exchange agreement 623,000 623,000
Warrant exchange agreement, shares         41,498        
Balance at Mar. 31, 2025 $ 1,000 $ 108,051,000 $ (81,000) $ (72,296,000) $ 35,675,000
Balance, shares at Mar. 31, 2025 734,025